Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1991 Nov;84(11):639–640. doi: 10.1177/014107689108401102

Haemorheological treatment of ischaemia--facts or fancy?

E Ernst
PMCID: PMC1295461  PMID: 1744864

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back T., von Kummer R. Blutverdünnung bei zerebraler Ischämie. Abschied von einem verbreiteten Behandlungskonzept. Dtsch Med Wochenschr. 1989 Mar 3;114(9):350–354. doi: 10.1055/s-0029-1235650. [DOI] [PubMed] [Google Scholar]
  2. Ernst E., Kollar L., Matrai A. A double-blind trial of Dextran-haemodilution vs. placebo in claudicants. J Intern Med. 1990 Jan;227(1):19–24. doi: 10.1111/j.1365-2796.1990.tb00113.x. [DOI] [PubMed] [Google Scholar]
  3. Ernst E., Matrai A., Kollar L. Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease. Lancet. 1987 Jun 27;1(8548):1449–1451. doi: 10.1016/s0140-6736(87)92204-5. [DOI] [PubMed] [Google Scholar]
  4. Ernst E. Plasma fibrinogen--an independent cardiovascular risk factor. J Intern Med. 1990 Jun;227(6):365–372. doi: 10.1111/j.1365-2796.1990.tb00174.x. [DOI] [PubMed] [Google Scholar]
  5. Ernst E. Therapeutic defibrinogenation in peripheral vascular disease. Int Angiol. 1985 Jul-Sep;4(3):373–377. [PubMed] [Google Scholar]
  6. GUYTON A. C., RICHARDSON T. Q. Effect of hematocrit on venous return. Circ Res. 1961 Jan;9:157–164. doi: 10.1161/01.res.9.1.157. [DOI] [PubMed] [Google Scholar]
  7. Haass A. Hämorheologische Therapie. Stand und Perspektiven. Nervenarzt. 1989 Sep;60(9):528–539. [PubMed] [Google Scholar]
  8. Lindgärde F., Jelnes R., Björkman H., Adielsson G., Kjellström T., Palmquist I., Stavenow L. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group. Circulation. 1989 Dec;80(6):1549–1556. doi: 10.1161/01.cir.80.6.1549. [DOI] [PubMed] [Google Scholar]
  9. Schuff-Werner P., Schütz E., Seyde W. C., Eisenhauer T., Janning G., Armstrong V. W., Seidel D. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest. 1989 Feb;19(1):30–37. doi: 10.1111/j.1365-2362.1989.tb00192.x. [DOI] [PubMed] [Google Scholar]
  10. Ward A., Clissold S. P. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987 Jul;34(1):50–97. doi: 10.2165/00003495-198734010-00003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES